Which medications in the drug class Cholesterol-lowering agents are used in the treatment of Cutaneous Cholesterol Emboli?

Updated: Apr 12, 2021
  • Author: Robert A Schwartz, MD, MPH; Chief Editor: Dirk M Elston, MD  more...
  • Print

Cholesterol-lowering agents

Cholesterol-lowering agents induce regression of atherosclerotic plaques.

Lovastatin (Mevacor)

Lovastatin competitively inhibits 3-hydroxyl-3-methylglutaryl-coenzyme A reductase, which catalyzes the rate-limiting step in cholesterol synthesis.

Cholestyramine (Questran)

Cholestyramine forms a nonabsorbable complex with bile acids in the intestine, which, in turn, inhibits enterohepatic reuptake of intestinal bile salts.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!